SRx Health Q1 net loss narrows to $6.38 million; net sales rise to $3.44 million

SRx Health Solutions Inc.

SRx Health Solutions Inc.

SRXH

0.00
  • SRX Health Solutions posted a net loss of USD 6.38 million for quarter ended March 31, 2026, narrowing from USD 10.15 million a year earlier.
  • Net sales were USD 3.44 million, gross margin was 37% with gross profit of USD 1.28 million.
  • Operating loss was USD 1.82 million, while interest expense totaled USD 1.78 million.
  • Adjusted EBITDA loss was USD 594,000.
  • Business reset continued following SRx Canada CCAA proceedings, with former specialty pharmacy and clinical operations wound down and focus shifted to Halo-branded pet food and wellness products.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SRX Health Solutions Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-023072), on May 14, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.